文献速递胸部CT

基于磨玻璃影表现评估淋巴血管侵犯对Ⅰ期肺腺癌的预后价值

The prognostic value of lymphovascular invasion for stage I lung adenocarcinoma based on the presence of ground-glass opacity.
PubMed 文献 · Eur Radiol · 2024-09-16

回顾性纳入2010至2019年接受肺叶切除术的924例Ⅰ期肺腺癌患者,按CT有无磨玻璃影分为磨玻璃影阳性与实性腺癌两组。淋巴血管侵犯在实性腺癌中显著多于磨玻璃影阳性腺癌(20.1% vs. 6.9%,p<0.001)。多因素分析显示淋巴血管侵犯仅与实性腺癌患者较短的无病生存期相关(HR 1.89,p=0.004),与两组总生存期均无显著相关。

要点

  • 实性Ⅰ期肺腺癌中淋巴血管侵犯显著多于磨玻璃影阳性腺癌(20.1% vs. 6.9%)。
  • 淋巴血管侵犯仅与实性腺癌较短无病生存期相关(HR 1.89,p=0.004)。
  • 淋巴血管侵犯与两组总生存期均无显著相关(p>0.05)。

核心结论

  • 在Ⅰ期肺腺癌中,病理证实的淋巴血管侵犯仅与实性肺腺癌患者的无病生存期相关,与磨玻璃影阳性腺癌患者无显著相关。

研究设计与样本

  • 回顾性研究,纳入2010至2019年接受肺叶切除术的Ⅰ期肺腺癌患者924例(平均年龄62.5±9.2岁,女性505例),按CT有无磨玻璃影分为磨玻璃影阳性组与磨玻璃影阴性(实性腺癌)组,采用多因素Cox回归分析无病生存期与总生存期。

关键影像表现/征象

  • CT上磨玻璃影阳性腺癌525例(56.8%),实性腺癌为磨玻璃影阴性者。
  • 淋巴血管侵犯在实性腺癌中占20.1%,在磨玻璃影阳性腺癌中占6.9%(p<0.001)。
  • 实性腺癌组中淋巴血管侵犯与较短无病生存期相关(HR 1.89,p=0.004),脏层胸膜侵犯亦相关(HR 1.65,p=0.003)。
  • 磨玻璃影阳性组中淋巴血管侵犯(p=0.76)与脏层胸膜侵犯(p=0.87)均与无病生存期无显著相关。
  • 淋巴血管侵犯与两组总生存期均无显著相关(p>0.05)。

诊断标准与关键数值

  • 以CT有无磨玻璃影将Ⅰ期肺腺癌分为磨玻璃影阳性与磨玻璃影阴性(实性腺癌)两组。
  • 实性腺癌组淋巴血管侵犯预测较短无病生存期的HR为1.89(p=0.004),脏层胸膜侵犯HR为1.65(p=0.003)。
  • 磨玻璃影阳性组淋巴血管侵犯与无病生存期无显著相关(p=0.76),脏层胸膜侵犯亦无显著相关(p=0.87)。
  • 两组中淋巴血管侵犯与总生存期均无显著相关(p>0.05)。

临床应用与阅片要点

  • 作者认为,结合CT磨玻璃影表现与淋巴血管侵犯进行风险分层,可能识别出受益于加强监测的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: There is still a debate regarding the prognostic implication of lymphovascular invasion (LVI) in stage I lung adenocarcinoma. Ground-glass opacity (GGO) on CT is known to correlate with a less invasive or lepidic component in adenocarcinoma, which may influence the strength of prognostic factors. This study aimed to explore the prognostic value of LVI in stage I lung adenocarcinoma based on the presence of GGO.

MATERIALS AND METHODS: Stage I lung adenocarcinoma patients receiving lobectomy between 2010 and 2019 were retrospectively categorized as GGO-positive or GGO-negative (solid adenocarcinoma) on CT. Multivariable Cox regression analyses were performed for disease-free survival (DFS) and overall survival (OS) to evaluate the prognostic significance of pathologic LVI based on the presence of GGO.

RESULTS: Of 924 patients included (mean age, 62.5 ± 9.2 years; 505 women), 525 (56.8%) exhibited GGO-positive adenocarcinoma and 116 (12.6%) were diagnosed with LVI. LVI was significantly more frequent in solid than GGO-positive adenocarcinoma (20.1% vs. 6.9%, p < 0.001). Multivariable analysis identified LVI and visceral pleural invasion (VPI) as significant prognostic factors for shorter DFS among solid adenocarcinoma patients (LVI, hazard ratio (HR): 1.89, p = 0.004; VPI, HR: 1.65, p = 0.003) but not GGO-positive patients (p = 0.76 and p = 0.87). In contrast, LVI was not a significant prognostic factor for OS in either group (p > 0.05).

CONCLUSION: In stage I lung adenocarcinoma, pathologic LVI was associated with DFS only in patients with solid lung adenocarcinoma.

CLINICAL RELEVANCE STATEMENT: Lymphovascular invasion (LVI) significantly affects disease-free survival in solid-stage I lung adenocarcinoma patients, but not those with ground-glass opacity (GGO) adenocarcinoma. Risk stratification considering both GGO on CT and LVI may identify patients benefiting from increased surveillance.

KEY POINTS: The presence of ground-glass opacity portends different prognoses for lung adenocarcinoma. In stage I lung adenocarcinoma, lymphovascular invasion (LVI) was significantly more frequent in solid adenocarcinomas than in ground-glass opacity (GGO)-positive adenocarcinomas. LVI was not associated with overall survival in patients with either solid adenocarcinomas or GGO adenocarcinomas.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Choe J, Lee SM, Park S, et al. The prognostic value of lymphovascular invasion for stage I lung adenocarcinoma based on the presence of ground-glass opacity. Eur Radiol. 2024. PMID: 39285027. doi:10.1007/s00330-024-11048-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。